BRCA2 and neoplasm: A recent study showed that SOX2 overexpression was found in a proportion of women with BRCA1 and BRCA2 mutations who underwent prophylactic salpingo-oophorectomy, and in the majority of patients with HGSOCs, irrespective of tumor stage (25).